Synthesis and in vitro assessment of novel water‐soluble dextran‐docetaxel conjugates as potential pH sensitive system for tumor‐targeted delivery
- 8 July 2017
- journal article
- research article
- Published by Wiley in Journal of Applied Polymer Science
- Vol. 134 (43)
Abstract
Docetaxel is a potent taxane agent mostly used in breast, lung, and prostate cancers. Its low water solubility is the major drawback that leads to use of Tween 80 as surfactant and ethanol as solvent in market formulation. But, these excipients cause severe hypersensitivity reactions. In this study, docetaxel was conjugated to biocompatible polymer, dextran 70 kDa, via a pH sensitive linker to enhance solubility and diminish the need of surfactants. Folic acid was also conjugated to dextran to provide targeted delivery. Synthesized conjugates were examined for solubility, hemo‐compatibility, stability, and cytotoxicity on MCF‐7 and MDA‐MB‐231 cell lines. Results showed about 1200‐fold enhancement in water solubility by dextran and 280‐fold by dextran‐folate conjugation. Conjugates released the drug in a pH‐dependent manner and faster hydrolysis was observed in pH 5.4 than physiological pH 7.4. Docetaxel‐dextran conjugates showed proper hemo‐compatibility and presented greater cytotoxicity than docetaxel solution. Higher cytotoxicity was seen in folate conjugated samples and the final conjugates targeted by folate would be suitable novel substitutions for currently marketed formulation. © 2017 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 2017, 134, 45457.Keywords
Funding Information
- Shiraz University of Medical Sciences (94-7586)
This publication has 23 references indexed in Scilit:
- Polyglutamic acid–PEG nanocapsules as long circulating carriers for the delivery of docetaxelEuropean Journal of Pharmaceutics and Biopharmaceutics, 2014
- The use of a tumor metastasis targeting peptide to deliver doxorubicin-containing liposomes to highly metastatic cancerBiomaterials, 2012
- Dextran conjugates in drug deliveryExpert Opinion on Drug Delivery, 2012
- Synthetic Modification of Carboxymethylcellulose and Use Thereof to Prepare a Nanoparticle Forming Conjugate of Docetaxel for Enhanced Cytotoxicity against Cancer CellsBioconjugate Chemistry, 2011
- Docetaxel-Loaded Pluronic P123 Polymeric Micelles: in Vitro and in Vivo EvaluationInternational Journal of Molecular Sciences, 2011
- Folate-targeted therapeutic and imaging agents for cancerCurrent Opinion in Chemical Biology, 2009
- Magnetic drug-targeting carrier encapsulated with thermosensitive smart polymer: Core–shell nanoparticle carrier and drug release responseActa Biomaterialia, 2007
- Liposome Formulation of Paclitaxel with Enhanced Solubility and StabilityDrug Delivery, 2007
- Hydrotropic Polymeric Micelles for Enhanced Paclitaxel Solubility: In Vitro and In Vivo CharacterizationBiomacromolecules, 2006
- Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid–PEG conjugatesAdvanced Drug Delivery Reviews, 2004